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Primary ciliary dyskinesia (PCD) is a genetic disease characterized by abnormalities in ciliary function, leading to compromised
airway clearance and chronic bacterial infection of the upper and lower airways. The compositions of these infections and the
relationships between their characteristics and disease presentation are poorly defined.We describe here the first systematic cul-
ture-independent evaluation of lower airway bacteriology in PCD. Thirty-three airway samples (26 from sputum, 7 from broncho-
alveolar lavage [BAL] fluid) were collected from 24 PCD patients aged 4 to 73 years. 16S rRNA quantitative PCR and
pyrosequencing were used to determine the bacterial loads and community compositions of the samples. Bacterial loads, which
ranged from 1.3 104 to 5.2 109 CFU/ml, were positively correlated with age (P 0.002) but not lung function. An analysis of
7,000 16S rRNA sequences per sample identified bacterial species belonging to 128 genera. The concurrently collected paired
samples showed high bacterial community similarity. The mean relative abundance of the dominant genera was 64.5% (standard
deviation [SD], 24.5), including taxa reported through standard diagnostic microbiology (members of the genera Pseudomonas,
Haemophilus, and Streptococcus) and those requiring specific ex vivo growth conditions (members of the genera Prevotella and
Porphyromonas). The significant correlations observed included a positive relationship between Pseudomonas aeruginosa rela-
tive abundance and age and a negative relationship between P. aeruginosa relative abundance and lung function. Members of
the genus Ralstoniawere also found to contribute substantially to the bacterial communities in a number of patients. Follow-up
samples from a subset of patients revealed high levels of bacterial community temporal stability. The detailed microbiological
characterization presented here provides a basis for the reassessment of the clinical management of PCD airway infections.
Primary ciliary dyskinesia (PCD) is a genetic disease character-ized by abnormal ciliary structure and function. While varia-
tions in diagnostic approaches make PCD prevalence difficult to
determine accurately, the reported incidence rates range from 1 in
2,000 to 1 in 40,000 (1).
Abnormal ciliary function leads to impairedmucociliary clear-
ance, chronic airway infection and inflammation, bronchiectasis,
and chronic otitis media (2). The consequence is airway stasis,
which is a unique characteristic of PCD compared with those of
other chronic lung diseases. In addition, the vast majority of pa-
tients with PCD have low nasal nitric oxide (nNO) levels, which
have a potential impact on innate immunity (3). Chronic produc-
tive cough and nasal congestion are almost universal, with chronic
bronchitis, recurrent pneumonia, and bronchiectasis also being
common in PCD patients. Lung disease in PCD begins early in
childhood, with considerable variation in the progression and se-
verity between individuals (1, 4). Situs inversus is present in ap-
proximately half of patients (4).
While chronic infections of the PCD airways are strongly asso-
ciated with morbidity and mortality (5), relatively little is known
about their bacterial composition. Anobservational culture-based
study from the United States reported nontypeable Haemophilus
influenzae, Staphylococcus aureus, Streptococcus pneumoniae, and
oropharyngeal species to be most frequently isolated from chil-
dren and adolescents, with Pseudomonas aeruginosa and nontu-
berculous mycobacteria being more common in adults and pa-
tients with advanced lung disease (6). However, the extent to
which these findings are representative of PCD patients more
widely, and the prevalence of species that are refractory to growth
under conditions that are used in standard diagnostic microbiol-
ogy, are not known.
Culture-independent analytical techniques, including next-
generation sequencing, have allowed for the detailed characteriza-
tion of lower airway bacterial communities associatedwith a range
of obstructive airway diseases. Such analyses have typically re-
vealed much greater bacterial diversity than is reported through
standard diagnostic microbiology (7–12), with a substantial con-
tribution often made by species requiring anaerobic conditions
for growth, including members of the genera Prevotella, Veillo-
nella, Propionibacterium, and Actinomyces (8, 13).
In most cases, evidence of a direct pathogenic role in lower
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airway infections for any single species remains to be demon-
strated. However, in cystic fibrosis (CF) (10, 14–16) and non-CF
bronchiectasis (17), the characteristics of the bacterial community
as a whole, such as the number of bacterial species present (rich-
ness) or their relative abundance (evenness), have been correlated
with clinical measures of disease severity and progression.
Whether similar bacterial communities develop in PCD air-
ways as a result of impaired clearance has not been reported pre-
viously. Obtaining a comprehensive and detailed characterization
of PCD lower airway bacteriology is therefore important, both to
identify the species thatmight contribute directly to airway disease
and to determine the potential markers of disease progression.
Our aim was to perform the first systematic evaluation of lower
airway bacteriology in PCD. In keeping with other conditions
where airway clearance is compromised, we hypothesized that a
culture-independent analysis of PCD respiratory samples would
reveal a greater bacterial diversity than that reported through di-
agnostic microbiology, and further, that the composition of this
airway microbiota would correlate with clinical measures of dis-
ease.
MATERIALS AND METHODS
Twenty-four patients were recruited from the adult and pediatric PCD
clinics at University Hospital Southampton. All had been diagnosed with
PCD by the national PCD service according to international diagnostic
guidelines (4, 18). Written informed consent was provided by patients or
parents (local and national research and development [R&D] and ethical
approvals CHI395 and 07/Q1702/109). The study population data are
summarized in Table 1 and the details, including those of the follow-up
samples, shown in Table S1 in the supplemental material. Ciliary abnor-
malities and cases of situs inversus are detailed in Table S2 in the supple-
mental material.
Twenty-six spontaneously expectorated sputum samples were col-
lected between July 2012 and February 2013 during routine appointments
(if stable) or during exacerbations. Exacerbationswere defined as a change
in respiratory symptoms that the PCD specialist considered to be caused
by a lower respiratory tract infection requiring antibiotic therapy. In ad-
dition, 7 bronchoalveolar lavage (BAL) fluid samples had been collected
from 5 PCD patients between 2002 and 2010. The sputum and BAL fluid
samples for molecular analysis were transferred to the laboratory on ice
and stored at80°C.
Standard diagnostic microbiology was performed on sample aliquots
at the Health Protection Agency South East Laboratory, in accordance
with standard protocols. Bacteria were pelleted from the BAL fluid sam-
ples by centrifugation, and the sputa and BAL fluid pellets were trans-
ported to King’s College London for molecular analysis.
Molecular analysis of bacterial community composition. DNA ex-
tractions were performed as described previously (17). An estimation of
bacterial cell numbers per unit volume of respiratory samples was
achieved by quantitative PCR (qPCR) as described previously (10). Am-
plicon pyrosequencing (bacterial tag-encoded FLX amplicon pyrose-
quencing [bTEFAP]) was also performed as described previously (19).
The detailed protocols for all analytical steps are provided in the supple-
mentalmaterial. Statistical analysis was performed using a variety of com-
puter packages, including XLStat, NCSS 2007, R, and NCSS 2010. Alpha
and beta diversity analyses were conducted as described previously (19–
22). Unless otherwise confirmed by species-specific PCR, the detected
bacteria are reported at the genus level.
A genus-specific PCR assay for Ralstonia was used as described previ-
ously (23). Specific PCR assays for Ralstonia respiraculi, Ralstonia insidi-
osa, Ralstonia pickettii, and Ralstonia mannitolilytica were performed as
described previously (23, 24). P. aeruginosa-specific PCR was performed
as described previously (25) and used to confirm the identifications
achieved through pyrosequencing. The primer details are given in Table
S3 in the supplemental material, and the reaction conditions are provided
in the supplemental material.
RESULTS AND DISCUSSION
By performing the first systematic assessment of PCD airway mi-
crobiota, our aimwas to examine the extent towhich relationships
exist between the features of airway bacterial community compo-
sition and clinical measures of disease. Further, we aimed to pro-
vide a microbiological basis for the management of chronic infec-
tions in this patient group.
A cross-sectional analysis was performed on samples from 24
patients (20 sputum, 4 BAL fluid). The study population was
broadly reflective of the PCD population, with a range of ciliary
phenotypes, ages, and severity of disease. Approximately half of
the patients were receiving prophylactic antibiotics, and a similar
proportion was receiving inhaled corticosteroids.
Comparisonof culture-independentandculture-basedanal-
yses. The culture-based diagnostic microbiology data are shown
in Table S4 in the supplementalmaterial. In a number of instances
where the recognized respiratory pathogens were reported by cul-
ture-based analysis, they were also found to have a high relative
abundance in sequencing profiles. For example, P. aeruginosawas
detected by culture in patients 5 and 15, representing 96.7 and 98.7
of the sequences, respectively. However, discrepancies were also
observed. For example, in patient 16, P. aeruginosa represented
96.2% of sequences but was not reported by culture. Further, P.
aeruginosa was detected in a further 8 patients at a low relative
abundance butwas not reported by diagnosticmicrobiology. Sim-
ilar discrepancies were observed for H. influenzae and S. pneu-
moniae.
Determination of total bacterial load. The initial stage of cul-
ture-independent analysis involved an assessment of the bacterial
density in the airway samples. Here, the total numbers of bacterial
cells per unit volume of respiratory secretion were determined by
qPCR. Bacterial loads ranged from 1.3 104 to 5.2 109 CFU/ml
(mean standard deviation [SD], 1.0 109 1.7 109CFU/ml)
and were significantly lower in BAL fluid samples than in sputum
TABLE 1 Summarized characteristics of study population
Subject characteristicsa Data
Male/female ratio 8/16
Age range (median) (yr) 4–73 (15)
FEV1 % pred (% [no.])
70 60 (15)
40–69 32 (8)
40 4 (1)
Stable at time of sampling (% [no.]) 84 (21)
Antibiotic therapy at time of sampling (% [no.]) 72 (18)
ICS inhaler (% [no.]) 48 (12)
Wet cough (% [no.]) 92 (23)
Rhinitis (% [no.]) 84 (21)
Sinusitis (% [no.]) 40 (10)
Situs inversus (% [no.]) 48 (12)
a One patient was too young for spirometry. Information regarding antibiotic
treatment and inhaled corticosteroid inhaler use was not available for one patient. FEV1
pred (%), forced expiratory volume in 1 s, expressed as a percentage of the predicted
volume; ICS, inhaled corticosteroid.
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samples (mean SD, 2.2 106 4.8 106 CFU/ml and 1.2
109 1.8109 CFU/ml, respectively; P 0.005). These bacterial
cell densities are broadly consistent with those reported in other
chronic respiratory bacterial infections, such as CF and non-CF
bronchiectasis, as assessed using the same analytical approach
(9, 17).
The observed bacterial loads were positively correlated with
patient age (P 0.002, Spearman’s correlation). However, a sig-
nificant correlation between age and lung function decline has
been reported previously (6) but was not detected here. Intui-
tively, increasing bacterial load might be linked with increasing
disease severity, and therefore the absence of a significant relation-
ship between bacterial load and lung function in our study is per-
haps surprising. However, longitudinal studies of PCD patients
suggest that the courses of lung function vary greatly between
patients (26), suggesting that larger studies are required to fully
define this relationship.
Airway bacterial community composition. The types of bac-
teria present in the PCD airway samples were assessed by 16S
rRNA gene pyrosequencing. A total of 311,996 sequences were
derived from the sample collection. After stringent sequence cu-
ration, a total of 187,071 bacterial sequences were carried forward,
representing an average of 7,482 sequences per sample (range, 902
to 17,586).
Across the sample collection, 128 separate genera were de-
tected, with an average of 24 per sample (SD, 11.2; range, 5 to 57).
Of these, 39 generawere detected only in one patient. The detected
genera were predominantly from the phyla Firmicutes, Proteobac-
teria, Actinobacteria, and Bacteroidetes, representing 30.4%,
28.9%, 17.2%, and 9.4% of the sequences, respectively. The occu-
pancy of the genera ranged from 1 to 21 patients, with a mean
frequency of 4.9 patients (SD, 5.1). Those genera detected in10
patients are listed in Table 2. Bacterial diversity was assessed using
three separate measures (richness, Shannon index, and Chao1)
(see Fig. S1 in the supplementalmaterial).However, no significant
correlations were found between community diversity and clini-
cal measures.
Given that complex microbial communities exist in the oro-
pharynx and upper respiratory tract, and that there is the potential
for bacteria to be introduced to the lower airways from the wider
environment, the detection of a broad phylogenetic range of bac-
terial species was expected. However, the relative abundances of
the detected genera varied greatly. The mean relative abundance
of the “dominant genus” (the genus representing the greatest pro-
portion of total sequence identities in each sample) was 64.5% of
all detected sequences (SD, 24.5; range, 19.9 to 99.5%). However,
many of the detected genera were present at a low relative abun-
dance; when rank ordered according to relative abundance, typi-
cally, only the seven most prevalent genera in each patient con-
tributed1% of the total bacterial signal.
While the clinical significance of a particular bacterial taxon
can be disproportionate to its relative abundance, in the lower
airways, a context thought to be free from substantial bacterial
colonization in healthy individuals, an argument can be made for
focusing first on those bacteria that are greatest in number (Table
3). These dominant genera included both those likely to be re-
ported through standard diagnostic microbiology (e.g., Pseu-
domonas, Haemophilus, and Streptococcus) and those unlikely to
be detectedwithout specific growth conditions being present (e.g.,
Prevotella). Further, the majority of genera detected in a high pro-
portion of patients, or at a high relative abundance, were those
commonly associatedwith the airways or oropharynx (Pseudomo-
nas, Haemophilus, Streptococcus, Neisseria, Prevotella, Veillonella,
Porphyromonas, and Actinomyces) or gastrointestinal tract or oral
cavity (Blautia and Campylobacter). In a number of cases, how-
ever, genera that did not fall into either of these groups were also
detected with a high relative abundance. For example, Ralstonia
species were detected in 17 of the 24 patients (68%) by 16S rRNA
gene sequencing analysis (see Table S5 in the supplemental mate-
rial), with a mean relative abundance of 20.4% (SD, 31.9; range,
0.1% to 89.6%), and represented the dominant genus in four pa-
tients.
The high prevalence of Ralstonia in PCD airway secretions ob-
servedherewarrants further consideration.Whileothernonferment-
ingGram-negativebacilli, includingP. aeruginosa,Acinetobacter bau-
mannii, Stenotrophomonas maltophilia, and Burkholderia cepacia
complex, have been recognized as common causes of respiratory
infection, the role of Ralstonia species is less well understood.
Some Ralstonia species have, however, previously been recovered
from a range of infection contexts (27), including the CF airway,
most commonly from the species R. mannitolilytica, R. pickettii,
and R. respiraculi (23). Here, the relative abundance of Ralstonia
species was significantly higher in BAL fluid samples than in spu-
tum samples (P 0.01, one-way analysis of variance [ANOVA]).
Due to the unanticipated high incidence of the genus in the PCD
samples analyzed here, genus-specific PCR was used to confirm
TABLE 2 Genera detected in 10 patients
Genus No. detected
Streptococcus 21
Neisseria 20
Haemophilus 20
Prevotella 20
Veillonella 20
Porphyromonas 19
Ralstonia 17
Actinomyces 16
Campylobacter 14
Corynebacterium 13
Blautia 13
Pseudomonas 12
Staphylococcus 11
Oribacterium 11
Candidate division tm7 11
Capnocytophaga 11
Selenomonas 11
Derxia 10
Tannerella 10
TABLE 3 Predominant genera detected
Genus
No. of patients in whom the
listed genus was dominant
Pseudomonas 5
Neisseria 5
Ralstonia 4
Haemophilus 4
Streptococcus 2
Prevotella 2
Airway Microbiology of PCD and Clinical Correlates
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the detection of Ralstonia species. A positive PCR result was ob-
tained for 17 of the 18 respiratory sample extracts in which Ral-
stoniawas detected by pyrosequencing and in a further three sam-
ples in which it was not (see Table S5 in the supplemental
material). Species-specific PCR detected R. pickettii in 18 samples
and R. mannitolilytica in two samples. R. respiraculi and R. insidi-
osa were not detected.
While not normally considered to be associated with virulence
(27) (and not observed to be negatively correlated with lung func-
tion in this study), the clinical significance of the detection of
Ralstonia species in PCD airway secretions remains to be deter-
mined. The previous occurrence of “pseudo-outbreaks” due to
contaminated diagnostic reagents (27)means that the detection of
Ralstonia species must be interpreted with some caution. How-
ever, the detection of more than one Ralstonia species within the
patient group perhaps suggests this was not the case here.
The high abundance of the genus Blastococcus in one patient is
also noteworthy.Members of this genus have been isolated from a
range of environmental contexts (5), with the species detected
here, Blastococcus aggregatus, associated with brackish water in
particular (28). The potential clinical significance of this species in
the PCD airway is not yet known.
Correlations of species relative abundance and hierarchical
cluster analysis. We investigated whether significant relation-
ships existed between the relative abundance of different bacterial
community members. A number of significant correlations were
identified and are listed in Table 4. Of particular note are the
significant negative correlation between the relative abundances
of Pseudomonas and Porphyromonas and the significant positive
correlations between a number of anaerobic genera, including
Prevotella,Neisseria, Porphyromonas, and Streptococcus. There are
several potential explanations for the existence of these relation-
ships. P. aeruginosa was present at a high relative abundance in a
number of samples, and the predominance of a single member of
the bacterial community in thisway can result in a reduction of the
relative abundances of other bacteria. However, in addition, these
negative correlations may also reflect differences in airway condi-
tions (particularly oxygen tension in the cases of anaerobic gen-
era), the ecological interactions between different bacterial spe-
cies, and the extent of the oropharyngeal contribution to sputum.
The predominance of either Pseudomonas or a mixed group of
facultative and obligate anaerobes has been reported in airway
samples from other contexts, including in CF (16).
Correlation of relative species abundance and clinical mea-
sures.Hierarchical cluster analysis was used to assess the extent to
which bacterial community structure correlated with clinical
measures. No clear relationships between patient data and com-
munity clustering were identified, although samples obtained by
BAL tended to cluster within a broad subgroup, suggesting amore
discrete composition compared to that for sputum samples (see
Fig. S2 in the supplemental material). A comparison of the com-
position of BAL fluid samples and sputum samples revealed that
the former contained significantly lower numbers of bacterial cells
(P 0.001, Wilcoxon rank sum test) and contained significantly
higher relative levels of the genera Ralstonia, Corynebacterium,
Staphylococcus, Anaerococcus, Propionibacterium, and Acinetobac-
ter (P 0.05). This divergence between sample typesmight reflect
bacterial community differences across the airway regions, the
contribution of oropharyngeal bacteria to expectorated sputum,
and the younger age of patients sampled using this approach.
Both positive and negative significant correlations were iden-
tified between the relative abundances of particular genera and
patient age, FEV1 (percent predicted), and dominant genus rela-
tive abundance (used here as a marker of bacterial overgrowth)
(Table 5). In particular, there were significant positive correla-
tions between P. aeruginosa relative abundance and both patient
TABLE 4 Significant correlations between relative genus abundance
levels
Data by correlate:
Spearman’s
coefficient
Significance
(P)1 2
Pseudomonas Porphyromonas 0.574b 0.003
Stenotrophomonas Prevotella 0.574b 0.003
Stenotrophomonas Haemophilus 0.420a 0.036
Stenotrophomonas Massilia 0.444a 0.026
Stenotrophomonas Nocardioides 0.541b 0.005
Stenotrophomonas Ralstonia 0.613b 0.001
Porphyromonas Streptococcus 0.538b 0.006
Porphyromonas Moryella 0.461a 0.020
Porphyromonas Neisseria 0.602b 0.001
Porphyromonas Prevotella 0.683b 0.000
Prevotella Neisseria 0.597b 0.002
Prevotella Streptococcus 0.453a 0.023
Prevotella Eikenella 0.494a 0.012
Eikenella Neisseria 0.413a 0.040
Haemophilus Streptococcus 0.470a 0.018
a P value of0.05.
b P value of0.01.
TABLE 5 Significant correlations between genus relative abundance and
patient age, FEV1 percent predicted, and the relative abundance of
dominant genus
Data by correlate:
Spearman’s
coefficient
Significance
(P)1 2
Pseudomonas Age 0.422a 0.036
Blautia 0.399a 0.048
Corynebacterium 0.594b 0.002
Ralstonia 0.614b 0.001
Staphylococcus 0.491a 0.013
Blautia FEV1 % pred
c 0.459a 0.024
Haemophilus 0.405a 0.050
Tannerella 0.445a 0.029
Pseudomonas 0.432a 0.035
Pseudomonas Dominant genus
abundance
0.413a 0.040
Actinomyces 0.447a 0.025
Blautia 0.521b 0.008
Campylobacter 0.445a 0.026
Capnocytophaga 0.603b 0.001
Haemophilus 0.425a 0.034
Oribacterium 0.434a 0.030
Porphyromonas 0.548b 0.005
Prevotella 0.409a 0.042
Streptococcus 0.756b 0.000
Tannerella 0.559b 0.004
Veillonella 0.547b 0.005
a P value of0.05.
b P value of0.01.
c FEV1 % pred, forced expiratory volume in 1 s, expressed as a percentage of the
predicted volume.
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age and dominant genus abundance and significant negative cor-
relations with FEV1 (percent predicted). These findings are in line
with the similar strong associations reported for Pseudomonas
with disease progression across a range of obstructive airway dis-
eases (6, 29, 30). Further, P. aeruginosa infection has been shown
to be associated with bronchiectasis and air trapping in PCD (31).
Significant positive associations were observed between the
genera Fusobacterium, Prevotella, Mycoplasma, Abiotrophia, and
Selenomonas and the occurrence of sinusitis. Of these, only the
association with Fusobacterium remained significant following
continuity correction (P  0.014, Pearson’s chi-square test).
While members of this genus would be unlikely to be isolated by
standard microbiological analysis of respiratory samples, they are
commonly associated with sinus infections (32).
Bacterial community temporal stability. Chronic infections
of CF lower airways can vary relatively little in terms of bacterial
community composition over periods of a year or more when
patients are clinically stable (10, 33). At the same time, the occur-
rence of exacerbations and the associated antibiotic therapies re-
sult in large-scale changes in community composition (34). We
therefore investigated whether a similar pattern also exists in PCD
infections through the analysis of a limited number of follow-up
samples.
First, analysiswas performedonpaired sputum samples, which
were collected at the samehospital visit and obtained from three of
the patients and used to assess intersample variation and technical
reproducibility (Fig. 1). Bray-Curtis similarity scores were used to
determine similarities between the paired samples. Scores of 0.93,
0.85, and 0.53 were obtained from the three sample pairs, respec-
tively, compared to 0.19 between the samples from all patients.
Bacterial community temporal stability was then assessed
through the analysis of follow-up samples obtained from four
patients in the study (Fig. 2). In three cases, both sample points
were obtained during times of stability, and in one case, the fol-
low-up sample was obtained during a period of exacerbation. Sta-
ble follow-up samples showed a high level of community stability,
even where the interval period between samples was 3.5 years
(Bray-Curtis similarity score, 0.9). However, when the second
sample was obtained during exacerbation, community similarity
was greatly reduced (Bray-Curtis similarity score, 0.32) despite an
intervening period of only 87 days. While based on only a small
group of patients, these longitudinal observations suggest that
bacterial community composition typically varies substantially
between individual patients but can remain remarkably stable for
given patients over long periods.
The relatively small size of the patient groups fromwhom sam-
FIG 1 Comparison of paired sputum samples obtained on the same day, with dominant genera indicated. The Bray-Curtis similarity coefficient is given for each
pair.
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ples were obtained represents a limitation of our study; this in part
reflects the rarity of PCD.The application of the analysis described
here to a larger patient population would present an opportunity
to compare the airway microbiology of PCD patients with that of
patients with other chronic lower respiratory infections, such as
CF and non-CF bronchiectasis. Such comparative analyses might
aid in the delineation of relationships between bacterial commu-
nity composition and airway characteristics, such as airway stasis
in the case of PCD. As such, this represents an important area for
future investigation. In addition, the study described here was
primarily cross-sectional; more detailed longitudinal analyses are
also likely to provide important additional insights into the rela-
tionships between bacterial community dynamics and disease
progression.
In conclusion, in providing an in-depth culture-independent
analysis of PCD lower airway microbiology, we highlight the po-
tential contributions of species that are unlikely to be isolated
through conventional diagnosticmicrobiology to disease progres-
sion. The data presented here provide insight into the processes
that take place in a respiratory system when bacterial clearance is
compromised, with relationships between bacterial community
composition and clinical measures of disease identified. These
findings and their implications for treatment nowwarrant further
investigation.
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